Novo Nordisk
NVO
$123.05
Share price
-0.78%
Change (1 day)
47.19%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Novo Nordisk (NVO) Fails to deliver data
Key failure to deliver metrics for Novo Nordisk:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.3 M
- Last 3 months FTD volume: $47.64 M
- Last year FTD volume: $0.12 B
Failures to deliver for Novo Nordisk (NVO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Novo Nordisk (NVO) - since 2013
Volume in USD (price x number of shares), data since 2013Novo Nordisk (NVO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $51.13 M | -42.36% |
| 2023 | $88.71 M | -11.66% |
| 2022 | $0.10 B | 125.23% |
| 2021 | $44.58 M | 70.14% |
| 2020 | $26.2 M | -57.24% |
| 2019 | $61.28 M | -22.47% |
| 2018 | $79.04 M | 3.14% |
| 2017 | $76.63 M | 5.66% |
| 2016 | $72.53 M | -28.24% |
| 2015 | $0.10 B | -51.63% |
| 2014 | $0.20 B | 598.64% |
| 2013 | $29.9 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $16.08 M | $0.32 B | 🇺🇸 USA |
 Eli Lilly LLY | $53.06 M | $0.12 B | 🇺🇸 USA |
 Sanofi SNY | $26.39 M | $50.57 M | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |